TABLE 4.
Effects of ferulic acid on lipid profiles and renal indicators in the serum of HFFD-fed rats.
Variable | Control | Model | FAL | FAH | AP |
Lipid profiles | |||||
TG (mmol/L) | 1.05 ± 0.23 | 2.30 ± 0.29** | 1.39 ± 0.52## | 1.41 ± 0.18*,# | 1.57 ± 0.33*,## |
LDL-C (mmol/L) | 0.58 ± 0.10 | 0.77 ± 0.18* | 0.51 ± 0.03# | 0.50 ± 0.04# | 0.42 ± 0.05## |
HDL-C (mmol/L) | 1.10 ± 0.12 | 0.78 ± 0.06** | 0.94 ± 0.13*,# | 0.99 ± 0.07## | 0.94 ± 0.17# |
FFA (mmol/L) | 0.75 ± 0.09 | 1.08 ± 0.12** | 0.94 ± 0.20* | 0.75 ± 0.08## | 0.80 ± 0.10## |
Renal indicators | |||||
UA (μmol/L) | 62.46 ± 2.31 | 91.27 ± 11.90** | 75.82 ± 9.74**,# | 65.81 ± 7.22## | 75.54 ± 3.07**,# |
BUN (mg/L) | 93.66 ± 7.81 | 160.01 ± 10.75** | 91.31 ± 10.21## | 100.82 ± 7.64## | 79.51 ± 7.92*,## |
CRE (μmol/L) | 55.65 ± 1.77 | 57.09 ± 3.00 | 55.54 ± 2.62 | 54.83 ± 2.75 | 51.04 ± 1.93## |
Data are presented as mean ± SD. *p < 0.05, **p < 0.01, vs. Control; #p < 0.05, ##p < 0.01, vs. Model. FAL, low dose of ferulic acid group administered of HFFD mixed with 0.05% ferulic acid; FAH, high dose of ferulic acid administered of HFFD mixed with 0.1% ferulic acid; AP, allopurinol group administered of HFFD mixed with 0.0145% allopurinol.